During the past decade, Metropolitan Cardiovascular Consultants LLC conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 3 clinical trials were completed, i.e. on average, 60% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 2 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Metropolitan Cardiovascular Consultants LLC" #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator and "National Heart, Lung, and Blood Institute (NHLBI)" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Metropolitan Cardiovascular Consultants LLC" are "Heart Failure" (3 trials), "Atherosclerotic Cardiovascular Disease" (2 trials) and "Coronary Heart Disease (CHD)" (1 trials). Many other conditions were trialed in "Metropolitan Cardiovascular Consultants LLC" in a lesser frequency.

Most popular intervention types in "Metropolitan Cardiovascular Consultants LLC" are "Drug" (4 trials), "Other" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Empagliflozin" (2 trials), "Biomarker-guided care NT-proBNP" (1 trials), "Evolocumab" (1 trials) and "Inclisiran sodium 300 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Metropolitan Cardiovascular Consultants LLC" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Metropolitan Cardiovascular Consultants LLC". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Metropolitan Cardiovascular Consultants LLC, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Metropolitan Cardiovascular Consultants LLC, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".